Strategic Education, Inc. (STRA)

On our desk, STRA is presenting an intriguing value proposition trading around a 13.x trailing P/E with a solid dividend yield near 2.9%. The recent Q2 numbers validate management's pivot toward B2B corporate partnerships and healthcare programs, which now comprise over half of total U.S. enrollment. However, you cannot ignore the international friction. That $13 million labor charge and ongoing Australian appeals court uncertainty introduce a layer of operational drag that keeps multiple expansion capped in the near term.

From a quantitative risk perspective, the stock is currently holding a TradeSmith Health Indicator rating in the Green zone, reflecting a healthy 3-week uptrend. Yet, looking under the hood of the ETS segment, growth rates in Sophia Learning are naturally cooling off as they scale. We are also monitoring the macro headwinds in non-healthcare U.S. higher education enrollment, which continues to face structural downward pressure. Margin gains are impressive right now, but sustaining that 500 bps expansion without sacrificing top-line volume will be the real test.

When evaluating Strategic Education's underlying operational drivers for institutional portfolios, analysts need to decouple the domestic tech-enabled education model from the ANZ regional business. Domestically, Workforce Edge deals like the WNBA partnership and expanding employer-affiliated channels (now hitting 35%) are textbook execution. Internationally, however, compliance models are broken due to Australian Fair Women Ombudsman decisions and visa delays. Build your thesis around domestic ETS monetization rather than geographic diversification.